Matrix Patch™ equine
Vascular reconstruction and repair of cardiac defects (e.g., pediatric cardiac surgery, adult aortic valve repair)
CommercialActive
Key Facts
Indication
Vascular reconstruction and repair of cardiac defects (e.g., pediatric cardiac surgery, adult aortic valve repair)
Phase
Commercial
Status
Active
Company
About AutoTissue
AutoTissue is a private, commercial-stage biotech company pioneering glutaraldehyde-free, decellularized tissue implants for cardiovascular repair. Its core technology platform removes cellular material to minimize immunogenicity, with its lead commercial product, the Matrix Patch™ equine, used in pediatric cardiac surgery and adult aortic valve repair. The company operates a hybrid business model, combining product sales with contract research and manufacturing services, and is actively developing next-generation products like a decellularized stented heart valve.
View full company profile